Loading...
Quality of life after postmastectomy radiotherapy in patients with intermediate-risk breast cancer (SUPREMO): 2-year follow-up results of a randomised controlled trial.
Velikova, G Williams, L Willis, S Dixon, J Loncaster, Juliette A Hatton, M Clarke, J Kunkler, I Russell, N
Velikova, G
Williams, L
Willis, S
Dixon, J
Loncaster, Juliette A
Hatton, M
Clarke, J
Kunkler, I
Russell, N
Citations
Altmetric:
Abstract
Postmastectomy radiotherapy in patients with four or more positive axillary nodes reduces breast cancer mortality, but its role in patients with one to three involved nodes is controversial. We assessed the effects of postmastectomy radiotherapy on quality of life (QOL) in women with intermediate-risk breast cancer.
Description
Date
2018-10-15
Publisher
Collections
Keywords
Type
Article
Citation
Quality of life after postmastectomy radiotherapy in patients with intermediate-risk breast cancer (SUPREMO): 2-year follow-up results of a randomised controlled trial. 2018 Lancet Oncol